First Time Loading...

AngioDynamics Inc
NASDAQ:ANGO

Watchlist Manager
AngioDynamics Inc Logo
AngioDynamics Inc
NASDAQ:ANGO
Watchlist
Price: 5.87 USD 2.98%
Updated: Mar 29, 2024

Intrinsic Value

ANGO's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

AngioDynamics, Inc. is a medical device company, which engages in the development, manufacture, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. [ Read More ]

The intrinsic value of one ANGO stock under the Base Case scenario is 16.17 USD. Compared to the current market price of 5.87 USD, AngioDynamics Inc is Undervalued by 64%.

Key Points:
ANGO Intrinsic Value
Base Case
16.17 USD
Undervaluation 64%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
AngioDynamics Inc

Backtest ANGO Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling ANGO stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

How can I assist you today?

Provide an overview
of AngioDynamics Inc's business.

What risks and challenges
does AngioDynamics Inc face in the near future?

Summarize the latest earnings report
of AngioDynamics Inc.

Provide P/E
for AngioDynamics Inc and its competitors.

Financials

Balance Sheet Decomposition
AngioDynamics Inc

Current Assets 185.5m
Cash & Short-Term Investments 60.9m
Receivables 51.6m
Other Current Assets 73m
Non-Current Assets 314.2m
PP&E 42.6m
Intangibles 263.1m
Other Non-Current Assets 8.5m
Current Liabilities 78m
Accounts Payable 37.7m
Accrued Liabilities 29.2m
Other Current Liabilities 11.2m
Non-Current Liabilities 20.4m
Other Non-Current Liabilities 20.4m
Efficiency

Earnings Waterfall
AngioDynamics Inc

Revenue
329.5m USD
Cost of Revenue
-162.4m USD
Gross Profit
167.2m USD
Operating Expenses
-191.9m USD
Operating Income
-24.8m USD
Other Expenses
10.6m USD
Net Income
-14.1m USD

Free Cash Flow Analysis
AngioDynamics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

ANGO Profitability Score
Profitability Due Diligence

AngioDynamics Inc's profitability score is 39/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
ROE is Increasing
Positive 3-Years Revenue Growth
Positive 1-Year Revenue Growth
39/100
Profitability
Score

AngioDynamics Inc's profitability score is 39/100. The higher the profitability score, the more profitable the company is.

ANGO Solvency Score
Solvency Due Diligence

AngioDynamics Inc's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Low D/E
Short-Term Solvency
Average Altman Z-Score
65/100
Solvency
Score

AngioDynamics Inc's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ANGO Price Targets Summary
AngioDynamics Inc

Wall Street analysts forecast ANGO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ANGO is 14.28 USD with a low forecast of 10.1 USD and a high forecast of 18.9 USD.

Lowest
Price Target
10.1 USD
72% Upside
Average
Price Target
14.28 USD
143% Upside
Highest
Price Target
18.9 USD
222% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

ANGO Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

ANGO Price
AngioDynamics Inc

1M 1M
+7%
6M 6M
-20%
1Y 1Y
-53%
3Y 3Y
-72%
5Y 5Y
-74%
10Y 10Y
-63%
Annual Price Range
5.87
52w Low
5.27
52w High
12.47
Price Metrics
Average Annual Return 0.29%
Standard Deviation of Annual Returns 62.55%
Max Drawdown -83%
Shares Statistics
Market Capitalization 233.9m USD
Shares Outstanding 40 219 000
Percentage of Shares Shorted 7.4%

ANGO Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

AngioDynamics Inc Logo
AngioDynamics Inc

Country

United States of America

Industry

Health Care

Market Cap

233.9m USD

Dividend Yield

0%

Description

AngioDynamics, Inc. is a medical device company, which engages in the development, manufacture, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. The company is headquartered in Latham, New York and currently employs 800 full-time employees. The company went IPO on 2004-05-27. Its devices are used in minimally invasive, image-guided procedures. Its product offerings include Endovascular Therapies, Oncology/Surgery (OS) and Vascular Access (VA). Its Endovascular Therapies product offerings support the medical areas of Thrombus Management, Atherectomy, Peripheral Products (Core) and Venous Insufficiency. Its OS product offerings includes a range of ablation technologies, including thermal tissue ablation systems, surgical resection and the Irreversible Electroporation (IRE) technology, the NanoKnife System. Its portfolio of VA products includes peripherally inserted central catheters (PICCs), midline catheters, implantable ports, dialysis catheters and related accessories and supplies.

Contact

NEW YORK
Latham
14 Plaza Dr
+15187981215.0
https://www.angiodynamics.com/

IPO

2004-05-27

Employees

800

Officers

CEO, President & Director
Mr. James C. Clemmer
Executive VP & CFO
Mr. Stephen A. Trowbridge
Senior VP and GM of Vascular Access & Oncology Global Business Unit
Mr. Chad T. Campbell
Senior VP & GM of International
Ms. Laura Piccinini
Vice President of Communications
Mr. Saleem M. Cheeks
Senior Vice President of Business Development
Mr. Benjamin H. Davis
Show More
Senior Vice President of Human Resources
Ms. Marna I. Bronfen-Moore
Senior Vice President of Quality & Regulatory Affairs
Mr. Warren G. Nighan
Senior Vice President of Information Technology
Ms. Kim L. Seabury
Senior VP & GM of Endovascular Therapies
Mr. Scott Centea
Show Less

See Also

Discover More
What is the Intrinsic Value of one ANGO stock?

The intrinsic value of one ANGO stock under the Base Case scenario is 16.17 USD.

Is ANGO stock undervalued or overvalued?

Compared to the current market price of 5.87 USD, AngioDynamics Inc is Undervalued by 64%.